Eagle Pharmaceuticals Inc (EGRX.OQ)
EGRX.OQ on NASDAQ Stock Exchange Global Market
49.69USD
5:30pm GMT
49.69USD
5:30pm GMT
Change (% chg)
$0.52 (+1.06%)
$0.52 (+1.06%)
Prev Close
$49.17
$49.17
Open
$49.38
$49.38
Day's High
$49.83
$49.83
Day's Low
$48.96
$48.96
Volume
18,635
18,635
Avg. Vol
96,195
96,195
52-wk High
$85.66
$85.66
52-wk Low
$36.10
$36.10
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 1.06 | December | 19 Mar 2019 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 1 | 1 |
| (2) OUTPERFORM | 1 | 1 | 1 | 1 |
| (3) HOLD | 3 | 3 | 3 | 3 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.40 | 2.40 | 2.40 | 2.40 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-19 | 4 | 52.78 | 55.03 | 50.30 | 49.60 |
| Quarter Ending Jun-19 | 4 | 56.22 | 61.39 | 53.00 | 53.20 |
| Year Ending Dec-19 | 5 | 224.18 | 242.72 | 204.00 | 224.08 |
| Year Ending Dec-20 | 5 | 241.64 | 276.30 | 202.20 | 252.77 |
| Earnings (per share) | |||||
| Quarter Ending Mar-19 | 3 | 1.06 | 1.14 | 1.01 | 1.10 |
| Quarter Ending Jun-19 | 3 | 1.10 | 1.21 | 1.04 | 1.19 |
| Year Ending Dec-19 | 5 | 4.62 | 5.45 | 4.14 | 4.19 |
| Year Ending Dec-20 | 5 | 4.85 | 6.24 | 3.11 | 4.92 |
| LT Growth Rate (%) | 1 | 2.50 | 2.50 | 2.50 | -- |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Dec-18 | 54.17 | 56.05 | 1.88 | 3.47 |
| Quarter Ending Sep-18 | 53.43 | 51.34 | 2.10 | 3.92 |
| Quarter Ending Jun-18 | 51.23 | 59.30 | 8.07 | 15.74 |
| Quarter Ending Mar-18 | 48.88 | 46.63 | 2.25 | 4.60 |
| Quarter Ending Dec-17 | 52.91 | 46.78 | 6.12 | 11.58 |
| Earnings (per share) | ||||
| Quarter Ending Dec-18 | 1.18 | 1.20 | 0.02 | 1.48 |
| Quarter Ending Sep-18 | 0.98 | 1.18 | 0.20 | 20.41 |
| Quarter Ending Jun-18 | 0.80 | 0.95 | 0.15 | 18.45 |
| Quarter Ending Mar-18 | 0.69 | 0.53 | 0.16 | 22.63 |
| Quarter Ending Dec-17 | 1.00 | 1.00 | 0.00 | 0.50 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-19 | 52.78 | 52.78 | 55.60 | 55.60 | 49.60 |
| Quarter Ending Jun-19 | 56.22 | 56.22 | 59.10 | 59.10 | 53.20 |
| Year Ending Dec-19 | 224.18 | 224.18 | 231.63 | 231.63 | 224.08 |
| Year Ending Dec-20 | 241.64 | 241.64 | 238.21 | 238.21 | 252.77 |
| Earnings (per share) | |||||
| Quarter Ending Mar-19 | 1.06 | 1.06 | 1.05 | 1.05 | 1.10 |
| Quarter Ending Jun-19 | 1.10 | 1.10 | 1.17 | 1.17 | 1.19 |
| Year Ending Dec-19 | 4.62 | 4.62 | 4.61 | 4.61 | 4.19 |
| Year Ending Dec-20 | 4.85 | 4.85 | 4.53 | 4.53 | 4.92 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Mar-19 | 0 | 0 | 0 | 3 |
| Quarter Ending Jun-19 | 0 | 0 | 0 | 3 |
| Year Ending Dec-19 | 0 | 0 | 0 | 4 |
| Year Ending Dec-20 | 0 | 0 | 1 | 3 |
| Earnings | ||||
| Quarter Ending Mar-19 | 0 | 0 | 1 | 1 |
| Quarter Ending Jun-19 | 0 | 0 | 1 | 1 |
| Year Ending Dec-19 | 0 | 0 | 2 | 1 |
| Year Ending Dec-20 | 0 | 0 | 1 | 1 |
Earnings vs. 
Estimates